Investigating Dystonia Remission

Profile view of a glowing human brain against a dark, cloud-like background.

This article was published in the Dystonia Dialogue. There are occasional reports of dystonia symptoms going into remission. Given the research and prognosis implications of this, investigators did a systematic review of reports of remission in the medical literature. They reviewed data from 2,551 cases with reports predominantly from individuals with cervical dystonia  or blepharospasm/Meige […]

The Singing Chef Andy LoRusso Cooks to Support DMRF

The Singing Chef Andy LoRusso is returning for a second year of Cooking for a Cure, a virtual event to benefit DMRF on Friday, January 28, 2022 at 5pm Pacific/7pm Central/8pm Eastern. He recently shared details about the event and how he became involved with DMRF. DMRF: We’re so pleased Cooking for a Cure is […]

September is Dystonia Awareness Month

An estimated 250,000 people in the United States have dystonia, a chronic movement disorder affecting the brain and nervous system. It is the third most common movement disorder after essential tremor and Parkinson disease. Dystonia causes excessive, uncontrollable muscle spasms. The muscle spasms twist the body and limbs into involuntary movements and awkward postures. Estimates […]

FDA Approves Xeomin® as First-Line Treatment for Focal Eye Dystonia

The US Food & Drug Administration (FDA) has approved the use of the botulinum neurotoxin Xeomin® (incobotulinumtoxinA) as a first-line treatment of blepharospasm in adults, as announced in a press release from Merz. Blepharospasm is a focal dystonia that causes muscles around the eyes to contract involuntarily. Individuals with blepharospasm may experience excessive blinking, light […]

en_USEnglish